Literature DB >> 9360989

Major histocompatibility complex class II-dependent unfolding, transport, and degradation of endogenous proteins.

G Aichinger1, L Karlsson, M R Jackson, M Vestberg, J H Vaughan, L Teyton, R I Lechler, P A Peterson.   

Abstract

We have analyzed the ability of major histocompatibility (MHC) class II molecules to capture proteins in the biosynthetic pathway and whether this may be associated with MHC class II-dependent antigen processing. When coexpressed with HLA-DR 4 molecules in HeLa cells, influenza hemagglutinin was inhibited from folding and trimerization in the biosynthetic pathway, targeted to endosomal compartments, and rapidly degraded. Due to the interaction with MHC class II molecules, therefore, unfolded forms of hemagglutinin were bypassing the quality control mechanism of the secretory pathway. More important, however, the transport, endocytosis, and rapid degradation of unfolded hemagglutinin in the presence of MHC class II molecules suggest that proteins captured in the endoplasmic reticulum by class II molecules may become substrates for antigen processing and presentation to CD4-positive T cells. In insect cells we show that this phenomenon is not restricted to a few proteins such as hemagglutinin. A highly heterogeneous mixture of proteins from the endoplasmic reticulum including coexpressed hemagglutinin can form stable complexes with soluble HLA-DR alpha and beta chains that were transported into the supernatant. This mechanism may gain biological significance in abnormal situations associated with accumulation of unfolded or malfolded proteins in the endoplasmic reticulum, for example during viral infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360989     DOI: 10.1074/jbc.272.46.29127

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

Review 2.  Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.

Authors:  Laurence C Eisenlohr; Nancy Luckashenak; Sebastien Apcher; Michael A Miller; Gomathinayagam Sinnathamby
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

3.  Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.

Authors:  Frank Thiele; Sha Tao; Yi Zhang; Andreas Muschaweckh; Tina Zollmann; Ulrike Protzer; Rubert Abele; Ingo Drexler
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

4.  LAMP-2C Inhibits MHC Class II Presentation of Cytoplasmic Antigens by Disrupting Chaperone-Mediated Autophagy.

Authors:  Liliana Pérez; Shawna McLetchie; Gail J Gardiner; Sarah N Deffit; Delu Zhou; Janice S Blum
Journal:  J Immunol       Date:  2016-02-08       Impact factor: 5.422

Review 5.  Prospects of a novel vaccination strategy for human gamma-herpesviruses.

Authors:  Ting-Ting Wu; Marcia A Blackman; Ren Sun
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

Review 6.  Autophagy, antiviral immunity, and viral countermeasures.

Authors:  Sanae Shoji-Kawata; Beth Levine
Journal:  Biochim Biophys Acta       Date:  2009-03-02

7.  Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells.

Authors:  Jacobus J Bosch; Uzoma K Iheagwara; Sarah Reid; Minu K Srivastava; Julie Wolf; Michal Lotem; Bruce R Ksander; Suzanne Ostrand-Rosenberg
Journal:  Cancer Immunol Immunother       Date:  2009-06-26       Impact factor: 6.968

8.  A Peptide/MHCII conformer generated in the presence of exchange peptide is substrate for HLA-DM editing.

Authors:  Andrea Ferrante; Jack Gorski
Journal:  Sci Rep       Date:  2012-04-27       Impact factor: 4.379

Review 9.  Virus-specific CD4+ T cells: ready for direct attack.

Authors:  Kevin N Heller; Cagan Gurer; Christian Münz
Journal:  J Exp Med       Date:  2006-03-20       Impact factor: 14.307

10.  Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii.

Authors:  Christopher D Dupont; David A Christian; Elizabeth M Selleck; Marion Pepper; Michael Leney-Greene; Gretchen Harms Pritchard; Anita A Koshy; Sagie Wagage; Morgan A Reuter; L David Sibley; Michael R Betts; Christopher A Hunter
Journal:  PLoS Pathog       Date:  2014-04-10       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.